Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobazam in Lennox-Gastaut Syndrome (CONTAIN)
NCT00518713Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Aug 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of clobazam in Lennox-Gastaut syndrome (LGS), sponsored by Lundbeck. Started Aug 2007; status: completed.
02
Drugs
clobazam
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on NCT00518713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518713.